EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of a health claim related to “Transitech” and “improves transit and durably regulates it” pursuant to Article 13(5) of Regulation (EC) No 1924/2006. / EFSA Publication.

Parma, Italy : European Food Safety Authority, 2012. 9 p. (The EFSA Journal; No. 2887, Vol. 10(8)).

Publication: Research - peer-review › Report – Annual report year: 2012

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of a health claim related to vitamin K2 and contribution to the normal function of the heart and blood vessels (ID 125, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. / EFSA Publication.

Parma, Italy : European Food Safety Authority, 2012. 18 p. (The EFSA Journal; No. 2714, Vol. 10(6)).

Publication: Research - peer-review › Report – Annual report year: 2012

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of a health claim related to Wheat Polar Lipid Extract and protection of the skin against dehydration pursuant to Article 13(5) of Regulation (EC) No 1924/2006. / EFSA Publication.

Parma, Italy : European Food Safety Authority, 2012. 11 p. (The EFSA Journal; No. 2773, Vol. 10(7)).

Publication: Research - peer-review › Report – Annual report year: 2012

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus acidophilus BCCM/LMG P-18806, Lactobacillus delbrueckii BCCM/LMG P-18805 and Streptococcus thermophilus BCCM/LMG P-18807 and reduction of gastro-intestinal discomfort (ID 2946, 2951, 2974), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 2946, 2951, 2974), improved lactose digestion (ID 2946, 2951, 2974), and reduction in numbers of circulating CD34+ cells (ID 2947, 2952, 2975) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. / EFSA Publication.

Parma, Italy : European Food Safety Authority, 2012. 23 p. (The EFSA Journal; No. 2855, Vol. 10(8)).

Publication: Research - peer-review › Report – Annual report year: 2012

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus fermentum 57A, Lactobacillus plantarum 57B and Lactobacillus gasseri 57C and defence against vaginal pathogens (ID 934, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006.. / EFSA Publication.

Parma, Italy : European Food Safety Authority, 2012. 15 p. (The EFSA Journal; No. 2719, Vol. 10(6)).

Publication: Research - peer-review › Report – Annual report year: 2012

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus gasseri PA 16/8, Bifidobacterium bifidum M 20/5 and Bifidobacterium longum SP 07/3 and maintenance of upper respiratory tract defence against pathogens (ID 931, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 : EFSA-Q-2012-00128 . / EFSA Publication.

Parma, Italy : European Food Safety Authority, 2012. 15 p. (The EFSA Journal; No. 2718, Vol. 10(6)).

Publication: Research - peer-review › Report – Annual report year: 2012

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus helveticus CNCM I-1722 and Bifidobacterium longum subsp. Longum CNCM I-3470 and alleviation of psychological stress (ID 938) and “maintains the balance of healthy microbiota that helps to strengthen the natural defence” (ID 2942) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. / EFSA Publication.

Parma, Italy : European Food Safety Authority, 2012. 18 p. (The EFSA Journal; No. 2849, Vol. 10(8)).

Publication: Research - peer-review › Report – Annual report year: 2012

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus paracasei CNCM I-1688 and Lactobacillus salivarius CNCM I-1794 and reduction of gastro-intestinal discomfort (ID 2972), decreasing potentially pathogenic gastrointestinal microorganisms (ID 2972), improved lactose digestion (ID 2972) and increasing IL-10 production (ID 2973) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. / EFSA Publication.

Parma, Italy : European Food Safety Authority, 2012. 20 p. (The EFSA Journal; No. 2856, Vol. 10(8)).

Publication: Research - peer-review › Report – Annual report year: 2012

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus rhamnosus CNCM I-1720 and Lactobacillus helveticus CNCM I-1722 and defence against pathogenic gastro-intestinal microorganisms (ID 939, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. / EFSA Publication.

Parma, Italy : European Food Safety Authority, 2012. 18 p. (The EFSA Journal; No. 2720, Vol. 10(6)).

Publication: Research - peer-review › Report – Annual report year: 2012

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus rhamnosus CNCM I-1720, Lactobacillus helveticus CNCM I-1722, Bifidobacterium longum CNCM I-3470 and Saccharomyces cerevisiae var. boulardii CNCM I-1079 and defence against pathogenic gastro-intestinal microorganisms (ID 3017, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. / EFSA Publication.

Parma, Italy : European Food Safety Authority, 2012. 16 p. (The EFSA Journal; No. 2853, Vol. 10(8)).

Publication: Research - peer-review › Report – Annual report year: 2012